Literature DB >> 11193241

Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs.

P D Delmas1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11193241     DOI: 10.1007/s001980070007

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  26 in total

Review 1.  Should the treatment of osteoporosis be more selective?

Authors:  B E Christopher Nordin
Journal:  Osteoporos Int       Date:  2003-03-12       Impact factor: 4.507

Review 2.  Clinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: why are the markers poorly accepted by clinicians?

Authors:  J J Stepan
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

3.  Acute effects of plyometric jumping and intermittent running on serum bone markers in young males.

Authors:  Che-Fu Lin; Tsang-hai Huang; Kuo-Cheng Tu; Linda L Lin; Yi-Hsuan Tu; Rong-Sen Yang
Journal:  Eur J Appl Physiol       Date:  2011-08-12       Impact factor: 3.078

4.  Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis.

Authors:  S Adami; J San Martin; M Muñoz-Torres; M J Econs; L Xie; G P Dalsky; M McClung; D Felsenberg; J P Brown; M L Brandi; A Sipos
Journal:  Osteoporos Int       Date:  2007-10-16       Impact factor: 4.507

5.  Biochemical markers of bone turnover: part I: biochemistry and variability.

Authors:  Markus J Seibel
Journal:  Clin Biochem Rev       Date:  2005-11

6.  A fracture does not adversely affect bone mineral density responses after teriparatide treatment.

Authors:  Aasis Unnanuntana; Quang V Ton; John P Kleimeyer; Joseph T Nguyen; Joseph M Lane
Journal:  Clin Orthop Relat Res       Date:  2011-08-24       Impact factor: 4.176

7.  The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.

Authors:  H P Bhattoa; P Bettembuk; A Balogh; G Szegedi; E Kiss
Journal:  Osteoporos Int       Date:  2003-12-16       Impact factor: 4.507

Review 8.  Bone as an effect compartment : models for uptake and release of drugs.

Authors:  David Stepensky; Lilach Kleinberg; Amnon Hoffman
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis.

Authors:  P Szulc; P D Delmas
Journal:  Osteoporos Int       Date:  2008-07-16       Impact factor: 4.507

10.  Enhancement of calcium/vitamin d supplement efficacy by administering concomitantly three key nutrients essential to bone collagen matrix for the treatment of osteopenia in middle-aged women: a one-year follow-up.

Authors:  Priscilla G Masse; Jean-Luc Jougleux; Carole C Tranchant; Juliana Dosy; Marcel Caissie; Stephen P Coburn
Journal:  J Clin Biochem Nutr       Date:  2009-12-29       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.